1.8476
Casi Pharmaceuticals Inc (CASI) 最新ニュース
CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated by Analysts at StockNews.com - Defense World
HC Wainwright Has Positive Forecast for CASI Q2 Earnings - Defense World
Transcript : CASI Pharmaceuticals, Inc.Special Call - marketscreener.com
CASI to Host Business and Clinical Update Conference Call | CASI Stock News - GuruFocus
CASI Pharmaceuticals Schedules Business Update Amid Legal Proceedings - TipRanks
CASI Pharmaceuticals (NASDAQ:CASI) Given “Buy” Rating at HC Wainwright - Defense World
CASI Pharmaceuticals: HC Wainwright & Co. Reiterates Buy Rating - GuruFocus
CASI Pharmaceuticals Provides Business and Clinical Update - ACCESS Newswire
CASI Pharmaceuticals Schedules Major Business and Clinical Pipeline Review: What Investors Should Watch - Stock Titan
Kaixin Pharmaceuticals Inc. entered into a definitive Equity and Assets Transfer Agreement to acquire Two subsidiaries in China from CASI Pharmaceuticals, Inc. for $20 million. - marketscreener.com
CASI Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CASI Pharmaceuticals Reports Q1 2025 Results and Asset Divestiture in China - TipRanks
CASI Pharmaceuticals Sees Revenue Boost in Q1 and Advances Key Program | CASI Stock News - GuruFocus
CASI Pharmaceuticals Announces First Quarter 2025 Business and Financial Results - ACCESS Newswire
CASI Pharmaceuticals Exits China in $20M Deal While Posting Record 82% Revenue Growth - Stock Titan
CASI Pharmaceuticals appoints new CFO - Investing.com
CASI Pharmaceuticals appoints new CFO By Investing.com - Investing.com India
CASI Pharmaceuticals Announces CFO Transition - TipRanks
CASI Pharmaceuticals Inc Daniel Lang To Step Down From His Role As Co'S Chief Financial Officer - marketscreener.com
CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com - Defense World
CASI Pharmaceuticals divests equity in Chinese subsidiaries By Investing.com - Investing.com Canada
CASI Pharmaceuticals Enters Into Definitive Agreement To Divest Assets in China - citybiz
CASI to Divest Two Subsidiaries in China - marketscreener.com
CASI Pharmaceuticals (CASI) Sells Equity and Rights to Kaixin Ph - GuruFocus
CASI Pharmaceuticals Divests Chinese Assets in $20 Million Deal - TipRanks
CASI Pharmaceuticals divests equity in Chinese subsidiaries - Investing.com
CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China - ACCESS Newswire
CASI Pharmaceuticals (CASI) to Release Earnings on Tuesday - Defense World
CASI Pharmaceuticals faces Nasdaq delisting over market value By Investing.com - Investing.com Nigeria
CASI Pharmaceuticals Faces Nasdaq Listing Compliance Challenge | CASI Stock News - GuruFocus
CASI Pharmaceuticals Faces Nasdaq Compliance Challenge - TipRanks
Casi Pharmaceuticals receives Nasdaq deficiency notice - TipRanks
CASI Pharmaceuticals faces Nasdaq delisting over market value - Investing.com Australia
CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement - ACCESS Newswire
StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI) - Defense World
CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia - ACCESS Newswire
CASI Pharmaceuticals, Inc.Ordinary Shares (NQ: CASI - FinancialContent
Brokers Issue Forecasts for CASI Q1 Earnings - Defense World
StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI) - Defense World
HC Wainwright Has Lowered Expectations for CASI Pharmaceuticals (NASDAQ:CASI) Stock Price - Defense World
CASI stock touches 52-week low at $1.88 amid market challenges - Investing.com
CASI Pharmaceuticals Moves to Arbitration in Dispute with Acrotech - TipRanks
CASI receives updated buyout offer for China operations - The Pharma Letter
CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely - Asianet Newsable
CASI Pharma stock hits 52-week low at $1.9 amid market challenges - Investing.com Australia
CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely Bullish - MSN
CASI Pharmaceuticals receives buyout proposal from CEO By Investing.com - Investing.com South Africa
大文字化:
|
ボリューム (24 時間):